Regulatory Constructs for Gerotherapeutic Drug, Biologic & Device Development: Afternoon Session

On May 27, 2026, the Reagan-Udall Foundation for the FDA, in collaboration with ARPA-H and XPRIZE Foundation, convened a hybrid public meeting on exploring regulatory constructs for gerotherapeutic drug, biologic and device development. XPRIZE Healthspan and ARPA-H PROSPR Awardees: Evidence Being Built at Scale (0:17) Regulatory Landscape: What Pathways Exist, Where They Break Down, and What Constructs are Needed (56:50) Industry Perspectives: What Product Sponsors Need from FDA to Bring Gerotherapeutics to Market (1:17:56) Next Steps to Designing Workable Regulatory Constructs for Gerotherapeutics (1:58:44)